You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 284 No. 8, August 23, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Contempo Updates: Linking Evidence and Experience
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Otolaryngology/ Head & Neck Surgery
 •Endocrine Disease of Head & Neck
 •Surgery
 •Surgical Interventions
 •Endocrine Surgery
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Management Changes in Primary Hyperparathyroidism

George L. Irvin III, MD; Denise M. Carneiro, MD

JAMA. 2000;284:934-936.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

With few exceptions, patients with hypercalcemia, normal renal function, and an elevated intact parathyroid hormone level have primary hyperparathyroidism. Currently, definitive treatment of this disease involves parathyroidectomy, which is the surgical removal of hypersecreting parathyroid gland(s), a procedure that involves surgical exploration of the neck, usually under general anesthesia. Patients with overt symptoms associated with this disease (eg, urinary tract stones, bone pain, cognitive symptoms) and marked hypercalcemia (calcium level >1.0 mg/dL [0.25 mmol/L] above normal range) are usually referred for parathyroidectomy. This procedure results in normocalcemia in 95% to 98% of patients and symptomatic improvement in 82%.1-3 A more difficult management dilemma occurs in the 80% of patients with hyperparathyroidism presenting with mild hypercalcemia and minimal or no symptoms.

In the last 10 years, several technological advances have influenced the diagnosis and treatment of patients with primary hyperparathyroidism. Perhaps the . . . [Full Text of this Article]

Guided Approaches to Parathyroidectomy

Suggested Management

Author Affiliations: Department of Surgery, Jackson Memorial Hospital, University of Miami and Department of Veterans Affairs Medical Center, Miami, Fla.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

August 23, 2000
JAMA. 2000;284(8):1035-1036.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Long-term Outcome of Patients With Elevated Parathyroid Hormone Levels After Successful Parathyroidectomy for Sporadic Primary Hyperparathyroidism
Solorzano et al.
Arch Surg 2008;143:659-663.
ABSTRACT | FULL TEXT  

The Effect of Parathyroidectomy on Bone Fracture Risk in Patients With Primary Hyperparathyroidism
VanderWalde et al.
Arch Surg 2006;141:885-891.
ABSTRACT | FULL TEXT  

Randomized Controlled Clinical Trial of Surgery Versus No Surgery in Patients with Mild Asymptomatic Primary Hyperparathyroidism
Rao et al.
J. Clin. Endocrinol. Metab. 2004;89:5415-5422.
ABSTRACT | FULL TEXT  

Worldwide Trends in the Surgical Treatment of Primary Hyperparathyroidism in the Era of Minimally Invasive Parathyroidectomy
Sackett et al.
Arch Surg 2002;137:1055-1059.
ABSTRACT | FULL TEXT  

Radioguidance Is Not Necessary During Parathyroidectomy
Inabnet III et al.
Arch Surg 2002;137:967-970.
ABSTRACT | FULL TEXT  

Evaluation of the Performance and Clinical Impact of a Rapid Intraoperative Parathyroid Hormone Assay in Conjunction with Preoperative Imaging and Concise Parathyroidectomy
Johnson et al.
Clin. Chem. 2001;47:919-925.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.